David S. Wilkes - Concepedia

Author

David S. Wilkes

Indiana University – Purdue University Indianapolis ORCID

Also Known As

D S Wilkes, D WILKES, D Wilkes, D. Wilkes, D.S. Wilkes, DAVID S. WILKES, David S Wilkes, David S. Wilkes, David Stephen Wilkes, David Wilkes

224

Publications

7.8K

Citations

H-Index

143

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine University of Michigan University of Pennsylvania Chiba University

About

David S. Wilkes is an author at Indiana University – Purdue University Indianapolis specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	39	2.9K
2	Public Health	3	3	684
3	African American Studies	3	3	686
4	Education	2	2	28
5	Health Sciences	2	2	37

David S. Wilkes

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation Joshua M. Diamond, James Lee, Steven M. Kawut, American Journal of Respiratory and Critical Care Medicine	2013	677
Race and Genetic Ancestry in Medicine — A Time for Reckoning with Racism Luisa N. Borrell, Jennifer R. Elhawary, Elena Fuentes‐Afflick, New England Journal of Medicine EthnicityFamily MedicineRacial Health EquityHealth Care DisparityGenetic Epidemiology	2021	627
IL-17–dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants William J. Burlingham, Robert B. Love, Ewa Jankowska−Gan, Journal of Clinical Investigation Inflammatory Lung DiseaseLung InflammationImmunologyPathologyImmunotherapy	2007	393
Evidence for Immune Responses to a Self-Antigen in Lung Transplantation: Role of Type V Collagen-Specific T Cells in the Pathogenesis of Lung Allograft Rejection Md Azizul Haque, Teruaki Mizobuchi, Kazuhiro Yasufuku, The Journal of Immunology	2002	183
Interleukin-9 Is Required for Allergic Airway Inflammation Mediated by the Cytokine TSLP Weiguo Yao, Yanlu Zhang, Rukhsana Jabeen, Immunity InflammationAsthmaCytokine TslpCytokineAllergy	2013	181
Anti-Type V Collagen Lymphocytes that Express IL-17 and IL-23 Induce Rejection Pathology in Fresh and Well-Healed Lung Transplants Satoshi Yoshida, Azizul Haque, Teruaki Mizobuchi, American Journal of Transplantation InflammationLung TransplantationTransplantationWell-healed Lung TransplantsImmunology	2006	166
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation Joshua M. Diamond, J.C. Lee, Steven M. Kawut, The Journal of Heart and Lung Transplantation TransplantationMedicineOutcomes ResearchGraft SurvivalClinical Risk Factors	2013	156
Neutralizing IL-17 Prevents Obliterative Bronchiolitis in Murine Orthotopic Lung Transplantation Lin Fan, Heather L. Benson, Ragini Vittal, American Journal of Transplantation	2011	153
Blockade of the Programmed Death-1 Pathway Restores Sarcoidosis CD4 <sup>+</sup> T-Cell Proliferative Capacity Nicole Braun, Lindsay J. Celada, Jose D. Herazo‐Maya, American Journal of Respiratory and Critical Care Medicine	2014	136
Refractory Sarcoidosis Responding to Infliximab * Scott D. Roberts, David S. Wilkes, Richard A. Burgett, CHEST Journal InflammationRheumatologyAnti-inflammatoryPulmonary PathologyRefractory Sarcoidosis Responding	2003	123

Page 1